Burney CO Merck & Co., Inc. Transaction History

Burney CO

$2.54 Billion
Q3 2024

A detailed history of Burney CO transactions in Merck & Co., Inc. stock. As of the latest transaction made, Burney CO holds 56,644 shares of MRK stock, worth $5.57 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

56,644

Previous 97,998 42.2%

Holding current value

$5.57 Million

Previous $12.1 Million 46.98%

% of portfolio

0.25%

Previous 0.51%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$111.15 - $128.97 $4.6 Million - $5.33 Million	-41,354 Reduced 42.2%	56,644 $6.43 Million
Q2 2024 Jul 29, 2024	SELL	$123.8 - $132.96 $544,348 - $584,625	-4,397 Reduced 4.29%	97,998 $12.1 Million
Q1 2024 May 22, 2024	BUY	$113.24 - $131.95 $816,460 - $951,359	7,210 Added 7.57%	102,395 $13.5 Million
Q4 2023 Feb 12, 2024	BUY	$100.18 - $109.02 $617,509 - $671,999	6,164 Added 6.92%	95,185 $10.4 Million
Q3 2023 Nov 08, 2023	BUY	$102.95 - $114.33 $3.83 Million - $4.25 Million	37,169 Added 71.68%	89,021 $9.16 Million
Q2 2023 Aug 09, 2023	BUY	$108.61 - $118.38 $1.78 Million - $1.95 Million	16,434 Added 46.4%	51,852 $5.98 Million
Q1 2023 May 10, 2023	SELL	$102.94 - $114.86 $122,910 - $137,142	-1,194 Reduced 3.26%	35,418 $3.77 Million
Q4 2022 Feb 06, 2023	SELL	$87.44 - $112.11 $248,242 - $318,280	-2,839 Reduced 7.2%	36,612 $4.06 Million
Q3 2022 Nov 15, 2022	BUY	$84.53 - $94.96 $132,458 - $148,802	1,567 Added 4.14%	39,451 $3.4 Million
Q2 2022 Aug 12, 2022	SELL	$83.49 - $94.64 $35,817 - $40,600	-429 Reduced 1.12%	37,884 $3.45 Million
Q1 2022 May 09, 2022	SELL	$73.51 - $82.4 $110,632 - $124,012	-1,505 Reduced 3.78%	38,313 $3.14 Million
Q4 2021 Feb 11, 2022	SELL	$72.28 - $90.54 $24,069 - $30,149	-333 Reduced 0.83%	39,818 $3.05 Million
Q3 2021 Nov 12, 2021	SELL	$71.68 - $78.83 $501 - $551	-7 Reduced 0.02%	40,151 $3.02 Million
Q2 2021 Aug 06, 2021	BUY	$70.31 - $77.77 $1.25 Million - $1.38 Million	17,756 Added 79.26%	40,158 $3.12 Million
Q1 2021 May 13, 2021	BUY	$68.86 - $81.11 $82,769 - $97,494	1,202 Added 5.67%	22,402 $1.73 Million
Q4 2020 Feb 11, 2021	SELL	$71.77 - $79.65 $105,788 - $117,404	-1,474 Reduced 6.5%	21,200 $1.73 Million
Q3 2020 Dec 14, 2020	BUY	$73.18 - $82.95 $28,247 - $32,018	386 Added 1.73%	22,674 $1.88 Million
Q2 2020 Aug 13, 2020	SELL	$70.42 - $80.13 $43,237 - $49,199	-614 Reduced 2.68%	22,288 $1.72 Million
Q1 2020 May 13, 2020	BUY	$63.36 - $87.82 $35,101 - $48,652	554 Added 2.48%	22,902 $1.76 Million
Q4 2019 Feb 14, 2020	BUY	$77.58 - $87.54 $245,928 - $277,501	3,170 Added 16.53%	22,348 $2.03 Million
Q3 2019 Nov 12, 2019	SELL	$76.08 - $82.93 $86,426 - $94,208	-1,136 Reduced 5.59%	19,178 $1.61 Million
Q2 2019 Aug 12, 2019	SELL	$69.84 - $81.59 $166,777 - $194,836	-2,388 Reduced 10.52%	20,314 $1.7 Million
Q1 2019 May 13, 2019	SELL	$69.58 - $79.36 $234,971 - $267,998	-3,377 Reduced 12.95%	22,702 $1.89 Million
Q4 2018 Feb 12, 2019	BUY	$65.24 - $75.71 $1,109 - $1,287	17 Added 0.07%	26,079 $1.99 Million
Q3 2018 Nov 13, 2018	SELL	$57.69 - $67.84 $411,098 - $483,427	-7,126 Reduced 21.47%	26,062 $1.85 Million
Q2 2018 Aug 13, 2018	BUY	$50.83 - $59.72 $175,719 - $206,452	3,457 Added 11.63%	33,188 $2.02 Million
Q1 2018 May 08, 2018	SELL	$50.96 - $59.23 $206,846 - $240,414	-4,059 Reduced 12.01%	29,731 $1.62 Million
Q4 2017 Feb 13, 2018	BUY	$51.62 - $61.64 $249,582 - $298,029	4,835 Added 16.7%	33,790 $1.9 Million
Q3 2017 Nov 13, 2017	BUY	$58.67 - $63.13 $38,722 - $41,665	660 Added 2.33%	28,955 $1.86 Million
Q3 2017 Nov 09, 2017	BUY	$58.67 - $63.13 $1.66 Million - $1.79 Million	28,295	28,295 $1.82 Million

Others Institutions Holding MRK

# of Institutions

3,814

Shares Held

1.88B

Call Options Held

14.6M

Put Options Held

13.2M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $249B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Burney CO, based on Form 13F filings with the SEC.

News

Stay updated on Burney CO with notifications on news.

Account